Form 4 Filing for Immuneering Corp

This filing details a transaction by Benjamin J. Zeskind, President and CEO of Immuneering Corp. On June 23, 2026, Mr. Zeskind acquired 2,400 shares of Class A Common Stock at a weighted average price of $4.56 per share. This acquisition was part of a series of trades with prices ranging from $4.55 to $4.59. Following this transaction, Mr. Zeskind directly owns 2,315,252 shares. Additionally, he has indirect ownership of 894,927 shares, held through the Benjamin J. Zeskind 2020 Family Trust, where his spouse, Lisa Schwartz, serves as the sole trustee. The filing was made on June 24, 2026.